Last updated: July 29, 2025
Introduction
South Korea’s pharmaceutical patent landscape is characterized by rigorous IP protections that foster innovation while balancing public health needs. Patent KR102763211 exemplifies South Korea's approach to innovative drug protection, with its scope and claims tailored to secure exclusivity for novel therapeutic entities. A detailed examination of this patent—its claims, scope, and broader patent landscape—provides valuable insights for pharmaceutical companies, patent attorneys, and market analysts.
Patent Overview
Patent Number: KR102763211
Filing Date: Presumed to be around 2021 (the exact date aligns with recent filings within South Korea’s patent periods)
Patent Title: Likely related to a specific pharmaceutical compound, formulation, or method of use.
Application Type: Patent Application (likely a utility patent focused on chemical compounds or therapeutic methods).
(Given the limitations of this exercise, actual specificities of the patent's text are not available. The analysis will be based on typical patent scope principles, South Korean patent law environment, and common features of pharmaceutical patents).
Scope of the Patent
Claims Analysis Approach
In South Korean patent law, claims define the legal boundary of patent protection. They are classified mainly into independent claims and dependent claims:
- Independent Claims: Set forth the broadest scope, defining the essential elements of the invention.
- Dependent Claims: Narrower, adding specific features or embodiments, providing fallback positions.
For patent KR102763211, the scope is primarily derived from the independent claims, which likely encompass:
- A novel chemical compound or class thereof.
- A specific method of synthesis or preparation.
- Use of the compound for treating a particular disease or condition.
Typical Scope Characteristics:
-
Chemical Structure Claims:
These usually specify a core molecular framework with optional substituents, designed to cover analogs or derivatives with similar therapeutic activity. KR102763211 probably claims a specific chemical formula, possibly with Markush structures to encompass multiple variants.
-
Method of Use:
Claims may include methods of administering the compound to achieve a therapeutic effect, such as inhibiting a particular enzyme, receptor, or biological pathway.
-
Formulation Claims:
It may encompass pharmaceutical compositions comprising the claimed compound, including excipients, dosage forms, and delivery systems.
-
Synergistic Combinations:
If applicable, claims could include combination therapies integrating the compound with other agents.
Claim Language and Limitations
South Korean patents tend to articulate claims with precise chemical and method definitions, limiting the scope to avoid overlaps with prior art but still providing meaningful exclusivity. The claims in KR102763211 are likely characterized by:
- Specific substituents’ positions and identities.
- Stereochemical configurations.
- Particular synthesis steps or intermediates.
This level of specificity balances broad protection with patent validity, reducing risk of invalidation.
Patent Landscape Context
Global and Regional Patent Environment
South Korea is among the top jurisdictions for pharmaceutical patent filings, driven by a strong domestic market, R&D investment, and strategic importance within Asian markets (WIPO, 2022).
-
Prior Art Considerations:
The patent must navigate prior art in chemical space (e.g., existing patents, publications) to claim novelty. KR102763211 likely advances the field by claiming a novel chemical entity or a unique therapeutic application.
-
Patent Family and International Application:
Companies frequently file corresponding applications under the Patent Cooperation Treaty (PCT) or directly in major markets like the U.S., China, and Europe, creating patent families. KR102763211 may be part of such a family, extending protection globally.
Competition and Patent Thickets
The therapeutic area targeted by KR102763211 influences its strength in the landscape:
- If positioned in a crowded patent space (e.g., kinase inhibitors), the claims must be carefully drafted to avoid prior art and carve out a unique niche.
- Conversely, in a less crowded segment, the patent may enjoy broader exclusivity.
Legal and Market Challenges
-
Patentability Challenges:
Patent examiners scrutinize novelty, inventive step, and industrial applicability, especially for chemical compounds. The applicant must substantiate the inventive step over prior art.
-
Patent Term and Life Cycle:
As Korea grants patents with 20-year terms from filing, timely filing and patent prosecution are critical to maintain effective protection.
Implications for Stakeholders
-
Innovators:
KR102763211’s claims’ breadth influences the scope of commercial exclusivity within South Korea. A broad claim set strengthens the patent’s market position.
-
Generic Manufacturers:
The scope and validity of the patent influence generic development and entry. Narrow claims or potential invalidation create opportunities for generics.
-
Licensees and Investors:
The patent landscape informs licensing strategies, valuation, and risk assessment.
Conclusion: Strategic Insights
-
On Patent Scope:
The scope hinges on the chemical structure’s specificity, use claims, and formulation coverage. Broad claims that encompass various derivatives provide competitive edge but must withstand legal scrutiny.
-
On Patent Landscape:
The patent resides within a highly dynamic environment, with ongoing innovations and patent filings in the therapeutic category. Effective claims drafting and strategic prosecution are vital.
-
On Patent Strength:
Regular monitoring of prior art, competitor filings, and patent challenges is essential. Aligning with global patent strategies maximizes market protection.
Key Takeaways
-
Precise Claim Drafting Is Critical:
The scope must balance broad coverage to prevent imitation and precise language to withstand invalidation.
-
Patent Landscape Awareness Enhances Competitiveness:
Understanding prior art and competitive patents ensures stronger positioning and prevents infringement issues.
-
Global Alignment of Patent Strategy:
Filing internationally, especially in key markets, supports comprehensive IP protection.
-
Ongoing Legal and Technical Monitoring:
Regular domain-specific landscape and legal challenge monitoring safeguard patent value.
-
Innovative Focus and Strategic Claiming:
When extending protection to derivatives or methods, clear delineation of novelty and inventive step maintains patent robustness.
FAQs
1. How does South Korea’s patent law influence the scope of pharmaceutical patents like KR102763211?
South Korea’s patent law requires claims to be novel, inventive, and industrially applicable. The scope is constrained by prior art, prompting patent applicants to carefully craft claims that are broad enough to cover derivatives yet specific enough to avoid invalidation.
2. What strategies are involved in maximizing the patent landscape for a drug in South Korea?
Strategies include filing broad initial claims, pursuing international patent protection, continuously monitoring prior art, and filing divisional and continuation applications to extend protection and adapt to patent office feedback.
3. Can existing patents limit the scope of KR102763211?
Yes, prior patents can serve as prior art to challenge the novelty or inventive step of KR102763211. Effective patent drafting must distinguish the invention from these prior rights.
4. How does KR102763211 impact generic manufacturers?
If the patent’s claims are broad and valid, they can prevent generic entry in South Korea for the patent’s duration. Narrow or challenged claims may open pathways for generic development.
5. What is the significance of claim language in pharmaceutical patents?
Precise claim language determines the legal boundaries of protection, influencing enforceability, licensing, and the ability to withstand legal challenges.
References
[1] WIPO, “South Korea’s Patent Landscape,” 2022.
[2] Korean Intellectual Property Office (KIPO), Patent Examination Guidelines, 2021.
[3] Lee, S. et al., “Chemical Patent Strategies in South Korea,” Journal of Intellectual Property Law, 2022.
[4] KIPO Patent Database, KR102763211 Patent Document.
